Literature DB >> 16443549

Consensus guideline for diagnosis and treatment of childhood idiopathic thrombocytopenic purpura.

Akira Shirahata1, Eiichi Ishii, Haruhiko Eguchi, Hiroji Okawa, Shigeru Ohta, Takashi Kaneko, Shozaburo Konishi, Masahiro Sako, Isao Sekine, Yukihiro Takahashi, Masashi Taki, Shigeru Tsuchiya, Kohji Fujisawa, Fumio Bessho, Yasuo Horikoshi, Junichi Mimaya, Jun-Ichi Akatsuka, Sumio Miyazaki.   

Abstract

A practice guideline aimed at standardizing the treatment for childhood idiopathic thrombocytopenic purpura (ITP) is presented. This consensus guideline is based on a survey carried out via a questionnaire prepared by the ITP Committee of the Japanese Society of Pediatric Hematology and sent to society members. The survey questionnaire included questions on the diagnosis of ITP submitted for the purpose of revising the ITP diagnostic guideline prepared in 1990 by the Research Group for Intractable Hematopoietic Disorders; a revised diagnostic guideline also is presented.

Entities:  

Mesh:

Year:  2006        PMID: 16443549     DOI: 10.1532/IJH97.05123

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  5 in total

1.  Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy.

Authors: 
Journal:  Br J Haematol       Date:  2003-02       Impact factor: 6.998

2.  Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group.

Authors:  O B Eden; J S Lilleyman
Journal:  Arch Dis Child       Date:  1992-08       Impact factor: 3.791

Review 3.  Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.

Authors:  J N George; S H Woolf; G E Raskob; J S Wasser; L M Aledort; P J Ballem; V S Blanchette; J B Bussel; D B Cines; J G Kelton; A E Lichtin; R McMillan; J A Okerbloom; D H Regan; I Warrier
Journal:  Blood       Date:  1996-07-01       Impact factor: 22.113

4.  A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura.

Authors:  K Fujisawa; H Iyori; H Ohkawa; S Konishi; F Bessho; A Shirahata; S Miyazaki; J Akatsuka
Journal:  Int J Hematol       Date:  2000-10       Impact factor: 2.490

Review 5.  Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica.

Authors:  D De Mattia; D Del Principe; G C Del Vecchio; M Jankovic; A Arrighini; P Giordano; A Menichelli; P Mori; M Zecca; A Pession
Journal:  Haematologica       Date:  2000-04       Impact factor: 9.941

  5 in total
  6 in total

1.  A characteristic flow cytometric pattern with broad forward scatter and narrowed side scatter helps diagnose immune thrombocytopenia (ITP).

Authors:  Raita Araki; Ryosei Nishimura; Rie Kuroda; Toshihiro Fujiki; Shintaro Mase; Kazuhiro Noguchi; Yasuhiro Ikawa; Hideaki Maeba; Akihiro Yachie
Journal:  Int J Hematol       Date:  2018-04-16       Impact factor: 2.490

2.  Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.

Authors:  Yoshihito Morimoto; Nao Yoshida; Nozomu Kawashima; Kimikazu Matsumoto; Koji Kato
Journal:  Int J Hematol       Date:  2014-02-27       Impact factor: 2.490

3.  Characterization of chronic idiopathic thrombocytopenic purpura in Japanese children: a retrospective multi-center study.

Authors:  Masaru Kubota; Souichi Adachi; Ikuya Usami; Masayuki Okada; Toshiyuki Kitoh; Mitsutaka Shiota; Yoshihiro Taniguchi; Akihiko Tanizawa; Mitsuhiko Nanbu; Keigo Hamahata; Hisanori Fujino; Kousaku Matsubara; Yoshihiro Wakazono; Tatsutoshi Nakahata
Journal:  Int J Hematol       Date:  2010-01-05       Impact factor: 2.490

4.  Standardized clinical assessment and management plans (SCAMPs): perspectives on a new method to understand treatment decisions and outcomes in immune thrombocytopenia.

Authors:  Rachael F Grace
Journal:  Semin Hematol       Date:  2013-01       Impact factor: 3.851

5.  Immune thrombocytopenic purpura risk by live, inactivated and simultaneous vaccinations among Japanese adults, children and infants: a matched case-control study.

Authors:  Hiroshi Yokomichi; Keiko Tanaka-Taya; Rie Koshida; Takashi Nakano; Yoshinori Yasui; Masaaki Mori; Yuka Ando; Saeko Morino; Hideo Okuno; Hiroshi Satoh; Satoru Arai; Mie Mochizuki; Zentaro Yamagata
Journal:  Int J Hematol       Date:  2020-04-06       Impact factor: 2.319

6.  The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Authors:  Seiichi Kato; Toshiaki Shimizu; Shigeru Toyoda; Benjamin D Gold; Shinobu Ida; Takashi Ishige; Shigeru Fujimura; Shigeru Kamiya; Mutsuko Konno; Kentaro Kuwabara; Kosuke Ushijima; Norikazu Yoshimura; Yoshiko Nakayama
Journal:  Pediatr Int       Date:  2020-12       Impact factor: 1.524

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.